Generic Drugs: Generic Viagra, Generic Cialis
GenericsHome
GENERIC DRUGS
1.
Sildenafil Citrate
2.
Tadalafil
3.
Caverta
4.
Silagra
5.
Kamagra
 

June 2007
April 2007
March 2007
Feb 2007
Jan 2007
Dec 2006
Nov 2006
Generic Drugs Facts
Why Generics Cost Less?
Viagra vs Generic Viagra
Myths About Generics
 

Home » News

» April 2007 » March 2007 » February 2007
» January 2007 » December 2006 » November 2006

Ministry seeks to boost generic drugs
23 April 2007: The government is seeking to boost the use of generic medicines by revamping the way doctors issue prescriptions.The plan is part of efforts to help curb snowballing medical bills by making patent-free pharmaceutical products more readily available.

India's Glenmark planning to launch 15 new generic drugs in Europe - report
28 March 2007: Glenmark Pharmaceuticals, which recently acquired Medicamenta AS of the Czech Republic, is planning to launch 15 new generic drugs in Europe over the next 2-3 years, the Economic Times reported citing Glenn Saldanha, chief executive and managing director of Glenmark.

Study Shows Incentive Program Increases Generic Drug Use
28 February 2007: A program that promotes greater use of generic medications, by waiving patient copayments for a limited time, is proven effective, according to a report released by Express Scripts, a leading pharmacy benefit manager.

Analysis confirms ED drugs OK for diabetic men
24 January 2007: Viagra and similar drugs used to treat erectile dysfunction, often referred to as ED, work for men with diabetes and appear to be safe, according to a research review being published Wednesday.

Generic drugs help trim health-care costs
9 January 2007: The Health care spending grew in 2005 at the slowest pace in six years thanks in part to a greater reliance on generic drugs. Spending went up 6.9 percent in 2005, approaching $2 trillion. That represents about $1 out of every $6 spent in the U.S., compared with about $1 out of every $10 in the early 1980s.

Generic drugs could save NHS 'millions'
28 December 2006: The new figures, released today by the Department of Health, show that around £85million could be saved a year if Primary Care Trusts (PCTs) prescribed generic versions of the drugs pravastatin and simvastatin, instead of their branded counterparts.

Home| About us | Contact Us | Articles | Disclaimer | Terms and Conditions

© 2005-2006 genericshome.com.All rights reserved.